Roni Oren
Weizmann Institute of Science(IL)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Diabetes and associated disorders, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, Prostate Cancer Treatment and Research
Most-Cited Works
- → miRNAs control insulin content in pancreatic β‐cells via downregulation of transcriptional repressors(2011)281 cited
- → The Catalytic Histidine Dyad of High Density Lipoprotein-associated Serum Paraoxonase-1 (PON1) Is Essential for PON1-mediated Inhibition of Low Density Lipoprotein Oxidation and Stimulation of Macrophage Cholesterol Efflux(2006)241 cited
- → Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma(2020)153 cited
- → Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo(2021)142 cited
- → Predicting and affecting response to cancer therapy based on pathway-level biomarkers(2020)114 cited
- → Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitors(2020)100 cited
- → Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity(2008)95 cited
- → Dysregulation of Dicer1 in Beta Cells Impairs Islet Architecture and Glucose Metabolism(2012)60 cited
- → Imaging aspects of the tumor stroma with therapeutic implications(2013)59 cited
- → Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor(2020)59 cited